|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 7/20/2023 1:09:22 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 2811, Limit, Save, Grow Act of 2023, provisions relating to Medicaid work requirements
H.R. 3746, Fiscal Responsibility Act of 2023, provisions relating to Medicaid work requirements
FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, provisions relating to FDA oversight authority/tobacco products and user fees
Gun Violence Prevention/research appropriations funding 2024
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1202, Resident Education Deferred Interest (REDI) Act, all provisions
S. 704, Resident Education Deferred Interest (REDI) Act, all provisions
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 3046, Medical Student Education Authorization Act of 2023, all provisions
S. 1403, Medical Student Education Authorization Act of 2023, all provisions
H.R. 2761, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions
S. 705, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions
H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions
S. 1302, Resident Physician Shortage Reduction Act of 2023, all provisions
H.R. 880, Heart Health Enhancement through Access to Research and Training (HEART) Act, all provisions
S. 703, Physicians for Underserved Areas Act, all provisions
Substance Use Disorder Workforce Act, all provisions
Opioid Workforce Act, all provisions
Improving Access to Health Care in Rural and Underserved Areas Act, all provisions
Indian Health Service Health Professions Tax Fairness Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 4189, To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes, all provisions
S. 2016, A bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes, all provisions
H.R. 830, Help Ensure Lower Patient (HELP) Copays Act, all provisions
S. 1375, Help Ensure Lower Patient (HELP) Copays Act, all provisions
H.R. 618, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions
S. 131, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions
H.R. 1770, Equitable Community Access to Pharmacist Services Act, all provisions
H.R. 2630, Safe Step Act, all provisions
S. 652, Safe Step Act, all provisions
H.R. 3432, Telemental Health Care Access Act of 2023, all provisions
S. 669, Increasing Mental Health Options Act of 2023, all provisions
S. 127, Pharmacy Benefit Manager Transparency Act of 2023, all provisions
S. 113, Prescription Pricing for the People Act of 2023, all provisions
H.R. 1359, Modernizing Opioid Treatment Access Act, all provisions
S. 644, Modernizing Opioid Treatment Access Act, all provisions
H.R. 467, Halt All Lethal Trafficking of (HALT) Fentanyl Act, all provisions
H.R. 3065, School Access to Naloxone Act of 2023, all provisions
H.R. 3752, Parity Enforcement Act of 2023, all provisions
H.R. 382, Pandemic is Over Act, all provisions
S. 1606, Black Maternal Health Momnibus Act, all provisions
H.R. 3910, Dillons Law, all provisions
Increasing Mental Health Options Act/House draft/psychologists prescribing
Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)/inclusion of H.R. 2819, Good Samaritan Health Professionals Act
21st Century Cures Act/implementation
Medication Access and Training Expansion (MATE) Act/implementation
Emergency Departments/residency shortages
Generic sterile injectable drugs/supply chain/payment issues
Reimbursement and coverage/breast reconstruction codes
Cybersecurity/Information Blocking
Reproductive health
Augmented Intelligence
Coding
Health Equity/maternal health
Substance use disorder
Diabetes/Obesity interventions
Mental health/Physician burnout
HIPAA/electronic health records
Abortion access
Vehicle emission standards
Public health security threats
Data sharing/consumer data privacy issues
988 Suicide and Crisis Lifeline
Permanent expansion of telehealth flexibility
Gender affirming care
Pharmacy Benefit Managers
Federal regulations on Gonad Shields
Digital health regulation/CPT
Clinical algorithms/bias/discrimination
Precision medicine
Laboratory developed tests/regulation
Misinformation/disinformation related to health care
Drug shortages
Drug compounding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Environmental Protection Agency (EPA), Substance Abuse & Mental Health Services Administration (SAMHSA), Food & Drug Administration (FDA), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Suzanne |
Joy |
|
|
|
Matthew |
Reid |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
Delosh |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S. 665, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Conrad State 30 and Physician Access Reauthorization Act/House draft
Healthcare Workforce Resilience Act/draft
H-1B International Medical Graduates/worksite practice flexibility
Undocumented immigrants/access to care
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), Labor - Dept of (DOL), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 113, Prescription Pricing for the People Act of 2023, all provisions
Insurance market competition
Competition in health care
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
George |
Cox |
III |
|
|
Lisa |
Myers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 1610, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
S. 799, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
H.R. 2474, Strengthening Medicare for Patients and Providers Act, all provisions
H.R. 2829, Chronic Care Management Improvement Act of 2023, all provisions
H.R. 1770, Equitable Community Access to Pharmacist Services Act, all provisions
H.R. 2377, Saving Access to Laboratory Services (SALSA) Act, all provisions
S. 1000, Saving Access to Laboratory Services (SALSA) Act, all provisions
S. 703, Physicians for Underserved Areas Act, all provisions
H.R. 977, Patient Access to Higher Quality Health Care Act of 2023, all provisions
S. 470, Patient Access to Higher Quality Health Care Act of 2023, all provisions
H.R. 1694, Emergency Care Improvement Act, all provisions
H.R. 4189, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023, all provisions
S. 2016, A bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes, all provisions
H.R. 1745, Medicare Fraud Detection and Deterrence Act of 2023, all provisions
H.R. 1746, Preventing Medicare Telefraud Act, all provisions
S. 1491, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions
S. 1246, Strengthening Medicare And Reducing Taxpayer (SMART) Prices Act, all provisions
H.R. 2811, Limit, Save, Grow Act of 2023, provisions relating to Medicaid work requirements
H.R. 3746, Fiscal Responsibility Act of 2023, provisions relating to Medicaid work requirements
H.R. 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023, provisions relating to Sections 101 and 105
H.R. 3281, Transparent PRICE Act, all provisions
H.R. 3248, Diagnostic Lab Testing Transparency Act, all provisions
S. 669, Increasing Mental Health Options Act of 2023, all provisions
H.R. 2713, Improving Care and Access to Nurses (I CAN) Act, all provisions
H.R. 3262, To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information, all provisions
H.R. 496, Freedom for Health Care Workers Act, all provisions
S. 1606, Black Maternal Health Momnibus Act, all provisions
S. 712, Connected MOM Act, all provisions
S. 1339, Pharmacy Benefit Manager Reform Act, all provisions
H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions
S. 1302, Resident Physician Shortage Reduction Act of 2023, all provisions
Amputation Reduction and Compassion (ARC) Act, all provisions
Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies (PREVENT DIABETES) Act, all provisions
Opioid Workforce Act, all provisions
Substance Use Disorder Workforce Act, all provisions
Increasing Mental Health Options Act/House draft/psychologists prescribing
Value in Healthcare Act
CONNECT for Health Act
Chronic Care Management Improvement Act of 2023
Medicare program: Making Care Primary/alternative payment model
Medicare program: Surprise medical billing
Medicare program: Physician payment reform
Medicare program: Physician inflation updates/Medicare Economic Index (MEI)
Medicare program: Budget neutrality
Medicare program: Physician-owned hospitals
Medicare program: Merit-based Incentive Payment System (MIPS) reforms/quality/cost/promoting interoperability/data sharing
Medicare program: MIPS/MSSP/Data Completeness and eCQM Adoption
Medicare program: Quality Payment Program/physician burdens
Medicare program: Medicare Payment Advisory Commission (MedPAC)/physician payment reform recommendations
Medicare program: Medicare Physician Payment - Add-on code
Medicare program: Medicare Advantage/Prior Authorization
Medicare program: Prior authorization regulation/include major provisions of Improving Seniors Timely Access to Care Act
Medicare program: Site Neutral Payment Policies
Medicare program: Medicare telehealth restrictions/permanent repeal
Medicare program: Health IT/physician burdens
Medicare program: Medicare Advantage cuts/Advanced Rate Notice
Medicare program: Electronic Health Records (EHR) certification
Medicare program: Remote patient monitoring/local coverage determinations
Medicare program: Patient engagement/quality data reporting
Medicare program: Residents in teaching settings/supervision through real-time audio visual technology
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS)/enrollment and validation
Medicare program: Open Payments
Medicare program: Prior authorization study update
Medicare and Medicaid programs: 21st Century Cures Act/implementation
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization (MACRA) Act/Broad reform
Medicare and Medicaid programs: MACRA/physician burdens
Medicare and Medicaid programs: Cybersecurity/Information Blocking
Medicare and Medicaid programs: Coding
Medicare and Medicaid programs: Substance use disorder
Medicare and Medicaid programs: Data privacy
Medicare and Medicaid programs: HIPAA/electronic health records
Medicare and Medicaid programs: Puerto Rico/physician payment inequities/access to care
Medicare and Medicaid programs: Undocumented immigrants/access to care
Medicaid program: Unwinding continuous enrollment
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
Delosh |
|
|
|
Bryan |
Hull |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Indian Health Service Health Professions Tax Fairness Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, provisions relating to FDA oversight authority/tobacco products and user fees
17. House(s) of Congress and Federal agencies Check if None
Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
Medical liability claim frequency
Algorithm liability
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 10, VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023, all provisions
H.R. 3347, Protect Lifesaving Anesthesia Care for Veterans Act of 2023, all provisions
S. 2070, Protect Lifesaving Anesthesia Care for Veterans Act of 2023, all provisions
S. 1606, Black Maternal Health Momnibus Act, all provisions
VA Supremacy Project/Scope of practice
Veterans Choice/Community Care Program
VA physician workforce shortage/scope of practice
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |